Influence of the Vitreomacular Interface on the Progression of the Diabetic Macular Edema After Anti-VEGF Injection

Fundació Institut Germans Trias i Pujol

Status: Completed

Conditions: Diabetic Macular Edema; Anti-VEGF Treatment; Vitreomacular Interface

Treatments: Drug: Intravitreal Ranibizumab injection

Study type: Observational

Funder types: Other

Identifiers

NCT02933905

OFT-RAN-2013-01

Details and patient eligibility

About

Influence of the vitreomacular interface on the progression of diabetic macular edema after treatment with intravitreal injection of vascular endothelial growth factor inhibitors

Enrollment: 38 patients

Sex: All

Ages: 18 to 90 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• diabetic macular edema treatable with antiangiogenic drugs

Exclusion criteria

• age under 18
• cardiovascular events during the last year
• previous vitrectomy
• previous macular edema treatment during the last 4 months

Trial design

38 participants in 2 patient groups

Non-PVD subjects

Description:

Patients with no PVD on SD-OCT at basal visit

Treatment:

Drug: Intravitreal Ranibizumab injection

PVD subjects

Description:

Patients with PVD on SD-OCT at basal visit

Treatment:

Drug: Intravitreal Ranibizumab injection